secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001104659-25-002841
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics reports preliminary Q4 2024 cash of ~$220M
---------------------------------------------------------------

- As of Dec 31, 2024, cash, cash equivalents and investments approx $220M.
- Preliminary, unaudited; subject to change upon completion of year-end closing procedures.
- Full year 2024 financial results to be included in upcoming Form 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925002841/0001104659-25-002841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925002841/tm253008d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-002841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer